DRUG · Unmapped registry intervention
Bryostatin 1
Find medicine records ·
Find other trials using this name
Clinical trial
Bryostatin Treatment of Moderately Severe Alzheimer's Disease
NCT04538066
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBryostatin Treatment of Moderately Severe Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
Bryostatin 1DRUG
PlaceboOTHER
Sponsors & collaborators
Neurotrope Bioscience, Inc.lead sponsor
National Institutes of Health (NIH)collaborator
National Institute on Aging (NIA)collaborator
Mapped research locations
St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San DiegoCalifornia, United States1PortlandOregon, United States1SpokaneWashington, United States1AlbanyNew York, United States1DecaturGeorgia, United States1HialeahFlorida, United States1SavannahGeorgia, United States1Fort WayneIndiana, United States1ColumbusGeorgia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04538066 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.